Olympus Crp Latex Reagent, OSR6199 and 2 more
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control. 510(k) K051564, from Olympus America, Inc. (Irving, TX). Product code NQD, class 2.
As of Nov 17, 2026, K051564 is an FDA 510(k) held by Olympus America, Inc., substantially equivalent on Aug 22, 2005 after 69 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Aug 22, 2005
- Review time: 69 days
- Recalls: 0
- Cited as a predicate by: 4 devices
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFOlympus System Reagent and calibrators for the quantitative determination of C-Reactive Protein in human serum and plasma on OLYMPUS Analyzers. Measurement of CRP is useful for the detection and evaluation of infection, tissue injury, inflammatory disorders and associated diseases.
Cited as a Predicate
4 later 510(k) summaries name this device as a predicate- CRP VarioK192118 · SENTINEL CH. SpA · Nov 8, 2019
- Yumizen C1200 CRPK192028 · Horiba Abx SAS · Jun 25, 2020
- ISE Reagent, Glucose, CRP Latex, DxC 700 AU Clinical Chemistry AnalyzerK161837 · Beckman Coulter, Inc. · Dec 16, 2016
- FastPack High Sensitivity C-Reactive Protein Immunoassay, High Sensitivity C-Reactive…K141689 · Qualigen, Inc. · Jan 7, 2015
Other NQD Clearances
The newest 510(k)s for the same product code; their median review was 112 days; see every NQD device- Tina-quant Cardiac high sensitivity CRP IIIK260026 · Roche Diagnostics · Apr 2, 2026
- Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2)K233242 · Siemens Healthcare Diagnostics, Inc. · Jan 18, 2024
- CardioPhase® hsCRPK212559 · Siemens Healthcare Diagnostics Products GmbH · Dec 16, 2022
Record
- Type
- Traditional
- Received
- Jun 14, 2005
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5270
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files